#gyncsm - a community for those impacted by gynecologic cancers Co-Founders: @womenofteal @btrfly12 Healthcare Moderators: @ShannonWestin @NitaKarnikLee
final chat held Dec 11, 2024
Joined August 2013
- Tweets36.2K
- Following5.8K
- Followers6.3K
- Likes6.2K
Pinned Tweet
It has been an honor and a privilege to be in community with all our #gyncsm participants and supporters.
Here's the recap of our final chat:
gyncsm.blogspot.com/2024/12/…
And you can continue to access all the resources on our blog: gyncsm.blogspot.com/p/resour…
GYN Cancer | #GYNCSM retweeted
🔊 🚫 Block your dates for 🚫 🔊
CASE OF THE MONTH #48 on 📹 zoom
CASE #48: Unresectable #advanced #tuboovarian carcinoma after neoadjuvant chemotherapy: personalized therapeutic strategies
#ovariancancer #advancedovariancancer #CRS #HIPEC #PIPAC
👨🏫 Moderated by Aditi Bhatt @writeslkpushkin
#Expert panel 🧑🏫 👨🏫 👩🏫 @artemstepanyan @somusp9 @drarturreis @PSugarbaker
📅 12th December, 2025, Friday
⏰ 4.00 pm CET
⏰ 10.00 am EST
⏰ 11.00 am Brazilian time
⏰ 10.30 pm Beijing
⏰ 3.00 pm UK/Ireland
📹 Join the meeting : us06web.zoom.us/j/8166141251…
📍 Meeting ID: 816 6141 2512
📍 Passcode: 350087
Or watch it 🆓 live on YouTube: youtube.com/@PSOGI_EC
Subscribe ✍ to the 🆕 newly launched Peritoneal Surface Oncology Group International (PSOGI) YouTube Channel
@indepso @DrFloresAyala @Bhandoria @agz_eriksson @glaucobaiocchi @CelestinoGutirr @CNevrez @IASO_IJSOonline
GYN Cancer | #GYNCSM retweeted
All things LGSOC next on #OC360LIVE with Dr. Rachel Grisham!
July 31, 10:00 AM CST
Join via Zoom: us02web.zoom.us/meeting/regi…
Have a question you would like to submit?
Email us at [email protected] by July 29 or you can Ask The Expert Live.
Learn. Ask. Share. Be Empowered!💪
GYN Cancer | #GYNCSM retweeted
RSVP: ovarcome.org/events/ovarcomi…
We are honored to announce the 1st Speaker of our Annual Conference on Sept. 18-19, @DrKatyMoore joining us to Talk About Therapies Now & On the Horizon For Gynecologic Cancers.
Join us and invite others -Dr. Moore invites you! 🩵
#OvarCon2025
GYN Cancer | #GYNCSM retweeted
RSVP: ovarcome.org/events/ovarcomi…
We are excited to announce our 2nd Speaker Dr. @RMWenham joining us to Talk About the Promise of Immunotherapy in Ovarcoming Ovarian Cancer. Join us for Ovarcoming Cancer - 2 days of information, insights, & inspiration! Dr. Wenham invites you!🩵
GYN Cancer | #GYNCSM retweeted
Stanford Cancer Institute invites you to the First Annual Stanford Gynecologic Oncology Research Symposium in honor of Dr. Jonathan S. Berek.
📅 Friday, September 12, 2025 • 8 AM–6 PM
📍 Li Ka Shing Center, Stanford School of Medicine & virtual
Join for a full day of research updates, panel discussions, and networking
Information in link in bio
Protein Keap1 regulates PRMT5 . In Chemo resistant OC this regulation is interrupted. Promising area of targeting treatment. #gyncsm
Northwestern Medicine scientists have identified a key driver of chemotherapy resistance in advanced #ovariancancer, according to a study led by @MazharAdli of @LurieCancer in @jclinicalinvest. news.feinberg.northwestern.e… #gyncsm
GYN Cancer | #GYNCSM retweeted
Make plans to participate in the 2025 #UterineCancer Awareness Month campaign – Accept the #UCAM #Jump4June Challenge! Plan a community activity this June or post your “jump” with facts and advocacy messages to about the most common #GynCancer this June. igcs.org/jump4june
Analysis of the global burden of #ovariancancer in adolescents
💡 bit.ly/3G7LN1Q
Enhancing the equitable allocation of health care resources to facilitate early diagnosis and treatment is essential for future treatment and research strategies.
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @thomasbartlMD @kfischermd @claritasantia @stephjeangill @MMontesinos_Alb @braunchristian1 @mattmarchettiMD @yates_elisemann @jhgelissen
GYN Cancer | #GYNCSM retweeted
Multi-center, international endometrial cancer consortium highlights sciencedirect.com/science/ar…. Thanks to our colleagues at Mayo Clinic for organizing this event.
🎉 NEW EPISODE ALERT!
Host Dr. Pearly Khaw sits down with Dr. David Gaffney for a wide-ranging conversation on the past, present, and future of gynecologic radiation oncology.
✨ Don’t miss this inspiring and insightful episode of the IGCS Education360 Podcast!
🎧 Available now at edu360.igcs.org
STAY INFORMED. Current CA-125 thresholds may miss racially and ethnically diverse patients with #ovariancancer, resulting in delayed chemotherapy initiation. #Ovarcome
ajmc.com/view/racial-differe…
🚨Is Fertility Preservation an Option in Unconventional Situations?
with Prof @aburustummd💐
🎥 m.youtube.com/watch?v=qDSgG0…
👋 Stay tuned for the fulltext publication @IJGConline
@drkahramanoglu @ENYGO_official
@ESGO_society @OncoAlert @gyncsm @GynMe4@OncoAlert
@TeamOvary_MSK
TP53 somatic evolution in the normal endometrium of Black and White individuals @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert @ISGynP @RiosDoriaMD sciencedirect.com/science/ar…
GYN Cancer | #GYNCSM retweeted
Can’t wait to join an incredible group of speakers on an exciting list of topics!!!
💐This May let your knowledge bloom at IOG 2025! Join Dr. Ritu Salani, MD, MBA & Dr. Kathleen Moore, MD as they debate and discuss the latest diagnostic, therapeutic, and supportive care strategies for patients with gynecologic malignancies and more: tinyurl.com/545en9zs
Disparities 📊 in facility-level adoption of minimally invasive interval debulking surgery for advanced ovarian cancer @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/ar…
🔬 The foundation of every cancer journey is a precise diagnosis.
At our 9th Annual Peritoneal Malignancy update, #MVRCANCON2025, our dedicated Pathology Workshop brings together global experts-including Prof. Frederic Bibeau-to highlight how
expert pathology drives better outcomes in peritoneal malignancy.
Secure your spot & learn why “good pathology saves lives”!
annualperitonealupdate2025.m…
@PSOGI_EC @MVRCancerCentre @myESMO @Pathologists @RCPath
GYN Cancer | #GYNCSM retweeted
🎖️Trainees in oncology and across all fields of medicine! Do not miss this manuscript on how to effectively respond to reviewer comments!
Thanks @VickersBiostats @redunndant @cgratzke @MRoupret @Albert0Briganti et al. @EUplatinum @EurUrolFocus @EurUrolOncol 🙏
@OncoAlert @ASCOTECAG @IMG_Oncologists @HemOncFellows @HemOncWomenDocs #MedEdCoP #Meded #OncTwitter @YaleIMed @ASCO @ASH_hematology
GYN Cancer | #GYNCSM retweeted
🚨Comparing Total Mesometrial Resection (TMMR) and Radical Hysterectomy (RH) in Early Cervical Cancer: Ontogenetic vs Traditional Anatomical Approaches.
Prof. David Cibula & Prof. Dr. Henrik Falconer
Dr. Nicolò Bizzarri & Dr. David Viveros
Link: buff.ly/loUK6PC
Molecular subtypes & genomic landscape of undifferentiated dedifferentiated endometrial ca pubmed.ncbi.nlm.nih.gov/4028… Undiff/dediff endometrial ca are heterogeneous; the majority are MSI-high/MMRd, may have therapeutic implications.@TeamEndo_MSK @TeamOvary_MSK @MSKCancerCenter
GYN Cancer | #GYNCSM retweeted
Science has never brought me to tears until today. This poster was presented at #AACR25. The study used a cell line based on paired molecular profiling of biopsies derived from my dear friend @ivybelkins cancer.
Ivy's voice helped shape research, and now her cells are helping to drive progress - a full circle moment. Thank you @alvaroonco, for recognizing and honoring Ivy's memory and contribution to research.
#LCSM #AdvocacyMatters #PowerOfPatientAdvocates
